Mara Arlind B, Gavitt Tyler D, Tulman Edan R, Geary Steven J, Szczepanek Steven M
Department of Pathobiology and Veterinary Science and the Center of Excellence for Vaccine Research, University of Connecticut, 61 North Eagleville Road, Unit 3089, Storrs, CT 06269 USA.
NPJ Vaccines. 2020 Apr 8;5(1):31. doi: 10.1038/s41541-020-0181-x. eCollection 2020.
Vaccine-enhanced disease (VED) occurs as a result of vaccination followed by infection with virulent . To date VED has prevented development of an efficacious vaccine against this significant human respiratory pathogen. Herein we report that vaccination of BALB/c mice with lipid-associated membrane proteins (LAMPs) induces lung lesions consistent with exacerbated disease following challenge, without reducing bacterial loads. Removal of lipid moieties from LAMPs prior to vaccination eliminates VED and reduces bacterial loads after infection. Collectively, these data indicate that lipid moieties of lipoproteins are the causative factors of VED.
疫苗增强性疾病(VED)是接种疫苗后再感染强毒株所致。迄今为止,VED阻碍了针对这种重要人类呼吸道病原体的有效疫苗的研发。在此,我们报告用脂质相关膜蛋白(LAMPs)对BALB/c小鼠进行疫苗接种后,再进行攻毒会诱发与病情加重相符的肺部病变,且不会降低细菌载量。在接种疫苗前去除LAMPs的脂质部分可消除VED,并降低感染后的细菌载量。总体而言,这些数据表明脂蛋白的脂质部分是VED的致病因素。